SCIEX Enhances Workflow Efficiency Through Software Innovations Backed by Six Strategic Industry Collaborations
SCIEX, a subsidiary of Danaher Corporation and a recognized leader in analytical technologies, is advancing its vision of a fully integrated digital ecosystem for modern laboratories through a series of strategic collaborations. The company recently highlighted six key industry partnerships that are helping to expand and strengthen its software environment, enabling scientists to navigate increasingly complex mass spectrometry workflows with greater efficiency, accuracy, and scalability.
As laboratory workflows become more data-intensive and multifaceted, software integration has emerged as a critical differentiator. Modern analytical labs must manage large volumes of data, ensure regulatory compliance, and maintain high levels of reproducibility—all while accelerating time to insight. In response to these demands, SCIEX has focused on building a unified software platform that seamlessly connects instrument control, method development, data processing, and compliance into a cohesive ecosystem.
At the core of this ecosystem is SCIEX’s approach to instrument control. Its software platform, known as SCIEX OS, serves as a central engine that powers the company’s mass spectrometry portfolio. Designed for both usability and performance, the platform allows scientists to monitor instrument conditions in real time, maintain data quality, and optimize uptime. By simplifying complex operational tasks, it enables laboratories to run more efficiently while minimizing the risk of errors.
Equally important is the platform’s role in method development. SCIEX has incorporated streamlined tools and guided optimization workflows that help researchers design robust and reproducible analytical methods. These capabilities significantly reduce turnaround times and improve experimental consistency. Features such as multiple reaction monitoring (MRM) prediction further enhance method accuracy, allowing scientists to refine assays more quickly and with greater confidence.
Data processing represents another cornerstone of the SCIEX software ecosystem. Modern mass spectrometry generates highly complex datasets that require sophisticated tools to extract meaningful insights. SCIEX’s integrated data processing solutions, combined with partner technologies, enable automated analysis, improved usability, and compliance-ready data integrity. This ensures that laboratories can not only generate high-quality results but also meet stringent regulatory requirements across industries such as pharmaceuticals, biotechnology, and clinical research.
According to Jose Castro-Perez, Vice President of Product Management at SCIEX, the growing complexity of mass spectrometry workflows makes software integration essential for achieving optimal outcomes. He emphasized that SCIEX’s holistic, data-driven approach provides customers with the tools needed to translate analytical data into actionable insights, ultimately driving scientific progress and operational success.
To further enhance its software ecosystem, SCIEX has established six strategic collaborations with leading technology providers. These partnerships extend the functionality of its platform and support a wide range of applications, from proteomics and biopharmaceutical analysis to high-throughput drug development.
One of the key collaborations is with Bioinformatics Solutions Inc., the developer of PEAKS. This AI-driven platform enables deep proteomic analysis by integrating advanced de novo sequencing, database and library searches, and detailed profiling of post-translational modifications (PTMs) and sequence variants. By combining these capabilities with quantitative workflows, PEAKS allows SCIEX users to extract comprehensive biological insights from complex datasets. Notably, Bioinformatics Solutions serves as the exclusive commercial partner for ZT Scan DIA data processing, positioning it at the forefront of next-generation data-independent acquisition technologies.
Another important partnership is with Protein Metrics, which provides the BYOS platform. BYOS enables detailed protein characterization across different mass spectrometry systems, allowing scientists to analyze even the most complex biopharmaceutical candidates. Its ability to quantify trace-level species and compare datasets enhances confidence in analytical results, which is particularly important in drug development and quality control.
SCIEX has also collaborated with the MacCoss Lab to integrate Skyline into its ecosystem. Skyline is widely used for developing and analyzing quantitative peptide workflows across various mass spectrometry platforms. It supports assay development, data visualization, and quantitative analysis using extracted ion chromatogram (XIC) strategies, making it a valuable tool for researchers working in targeted proteomics.
In the area of automation and artificial intelligence, SCIEX has partnered with Mass Analytica to offer AI Quantitation. This solution leverages AI and machine learning to automate data processing for both relative and absolute quantitation workflows. By incorporating MRM prediction and reducing manual intervention, the software helps laboratories improve productivity and free up valuable operator time, enabling scientists to focus on higher-value analytical tasks.
Another collaboration involves Genedata and its Expressionist platform. Designed for enterprise-level applications, Expressionist streamlines mass spectrometry workflows across multiple instruments and teams. It automates data processing and harmonizes workflows, ensuring consistency and accuracy across large-scale operations. The platform also supports regulatory compliance, making it particularly relevant for pharmaceutical and biotechnology companies operating in highly regulated environments.
Finally, SCIEX has partnered with Sound Analytics to integrate Leadscape into its ecosystem. Leadscape is designed to support high-throughput quantitative workflows, particularly in absorption, distribution, metabolism, and excretion (ADME) studies. By simplifying and accelerating MRM method development, the software enhances productivity and reduces turnaround times in drug candidate analysis.
Together, these six collaborations illustrate SCIEX’s commitment to building a comprehensive and flexible software environment that can adapt to the evolving needs of modern laboratories. By integrating best-in-class tools from across the industry, the company is enabling scientists to move more efficiently from data acquisition to insight generation.
Looking ahead, SCIEX plans to further expand its ecosystem with additional collaborations, which are expected to be announced at ASMS 2026. These future developments will likely continue to enhance the company’s ability to deliver end-to-end solutions for complex analytical workflows.
In conclusion, SCIEX’s integrated software strategy represents a significant step forward in the digital transformation of laboratory science. By unifying instrument control, method development, data processing, and compliance within a single ecosystem—and augmenting it through strategic partnerships—the company is helping to redefine how mass spectrometry is used in research, diagnostics, and drug development. As analytical challenges continue to grow in complexity, such integrated solutions will play an increasingly vital role in enabling scientific innovation and improving outcomes across the life sciences.
ABOUT SCIEX
SCIEX, a Danaher company and leader in life science analytical technologies, empowers our customers to solve the most impactful analytical challenges in quantitation and characterization. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field for over 50 years.
Since the launch of the first-ever commercially successful triple quadrupole in 1981, we continue to develop technologies and solutions that influence life-changing research and outcomes. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust.
Advances in human wellness depend on the power of precise science.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them.
Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow.
Source Link:https://www.businesswire.com/
